Improving the Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 is a research paper published in Clinical Infectious Diseases (2021). On theSindex it has a DataRank of 3.5. It has been cited 58 times, with 54 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.612
From this paper's citation signal
Citation Network Contribution
2.9
From 45 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 54 citers.
National Institutes of Health
Grant: K23AI154546
National Institutes of Health
Grant: 1K23AI154546-01A1
The Gut Microbiome in Carbapenem-Resistant Enterobacteriaceae Colonization, Persistence, Infection, and Tolerance after Lung or Liver Transplantation
National Institute of Allergy and Infectious Diseases
FWCI
3.10
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals